cgp 42112a has been researched along with l 162313 in 3 studies
Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (l 162313) | Trials (l 162313) | Recent Studies (post-2010) (l 162313) |
---|---|---|---|---|---|
233 | 0 | 35 | 31 | 0 | 10 |
Protein | Taxonomy | cgp 42112a (IC50) | l 162313 (IC50) |
---|---|---|---|
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0011 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0011 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0011 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
Type-2 angiotensin II receptor | Homo sapiens (human) | 0.002 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Juillerat-Jeanneret, L | 1 |
Armstead, WM; Baranov, D | 1 |
Hongo, S; Kanome, T; Miyazaki, A; Nishio, K; Takahashi, K; Watanabe, T | 1 |
1 review(s) available for cgp 42112a and l 162313
Article | Year |
---|---|
The Other Angiotensin II Receptor: AT
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Drug Delivery Systems; Humans; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2020 |
2 other study(ies) available for cgp 42112a and l 162313
Article | Year |
---|---|
Nitric oxide contributes to AT2 but not AT1 angiotensin II receptor-mediated vasodilatation of porcine pial arteries and arterioles.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Arteries; Biphenyl Compounds; Enzyme Inhibitors; Female; Imidazoles; Male; Naphthyridines; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Pia Mater; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Swine; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2005 |
Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Atherosclerosis; Benzimidazoles; Biphenyl Compounds; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Endocytosis; Foam Cells; Humans; Imidazoles; Macrophages; Male; Oligopeptides; Radioimmunoassay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Signal Transduction; Sterol O-Acyltransferase; Tetrazoles; Up-Regulation; Vasoconstrictor Agents; Vasodilator Agents | 2008 |